OSE — Ose Immunotherapeutics SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Ose Immunotherapeutics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	25.8	29.4	33.6	25.6	18.7
Net Total Accounts Receivable
Net Total Receivables	5.43	7.97	7.66	8.13	0.982
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33.1	39.8	44.2	37.2	30.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.7	3.79	5.44	4.98	4.07
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	88.9	97	102	91.8	82.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.3	14.1	16.8	16.3	18.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	30.4	35.6	54	59.1	59.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	58.5	61.4	47.9	32.7	23
Total Liabilities & Shareholders' Equity	88.9	97	102	91.8	82.1
Total Common Shares Outstanding